Abstract
e12080Background: Although the prognosis of patients with small、HER2-over expressing breast cancer is generally good, it is controversial how to make personalize adjuvant trastuzumab therapy strate...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
